YM458

YM458 is a dual EZH2/BRD4 inhibitor with IC50 values of 490 nM and 34 nM, respectively. It demonstrates potent anticancer activity in vitro by inhibiting proliferation, inducing cell cycle arrest and apoptosis in solid tumor models, supporting its use in oncology research.